Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson's Disease Patients
Yanyan Jiang, Jing Chen, Yunchuang Sun, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 21

Showing 21 citing articles:

Diagnostic Value of Salivary Real‐Time Quaking‐Induced Conversion in Parkinson's Disease and Multiple System Atrophy
Mingyue Luan, Yunchuang Sun, Jing Chen, et al.
Movement Disorders (2022) Vol. 37, Iss. 5, pp. 1059-1063
Closed Access | Times Cited: 64
Biomarkers in neurodegenerative diseases: a broad overview
Selvam Sathish, Velpandi Ayyavoo
Exploration of Neuroprotective Therapy (2024), pp. 119-147
Open Access | Times Cited: 10
Salivary Biomarkers for Parkinson’s Disease: A Systematic Review with Meta-Analysis
Kacper Nijakowski, Wojciech Owecki, Jakub Jankowski, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 340-340
Open Access | Times Cited: 9
The potential roles of salivary biomarkers in neurodegenerative diseases
Lingling Jiao, Hui-Lin Dong, Meng-Meng Liu, et al.
Neurobiology of Disease (2024) Vol. 193, pp. 106442-106442
Open Access | Times Cited: 9
The Role of Non-Coding RNAs in the Pathogenesis of Parkinson’s Disease: Recent Advancement
Hanwen Zhang, Longping Yao, Zijian Zheng, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 811-811
Open Access | Times Cited: 29
Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies
A Chopra, Tiago F. Outeiro
Brain (2023) Vol. 147, Iss. 1, pp. 81-90
Closed Access | Times Cited: 14
A systematic review of salivary biomarkers in Parkinson’s disease
M Bartolo, Daniele Belvisi, Romina Mancinelli, et al.
Neural Regeneration Research (2024) Vol. 19, Iss. 12, pp. 2613-2625
Open Access | Times Cited: 6
Sample‐to‐answer salivary miRNA testing: New frontiers in point‐of‐care diagnostic technologies
Zhikun Zhang, Tianyi Liu, Ming Dong, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 3
Closed Access | Times Cited: 5
Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives
Adelaida Hernaiz, Janne M. Toivonen, Rosa Bolea, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12609-12609
Open Access | Times Cited: 17
MicroRNAs in Parkinson’s disease: a systematic review and diagnostic accuracy meta-analysis
Diane Guévremont, Joyeeta Roy, Nicholas J. Cutfield, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
MiR-29a inhibits MPP + - Induced cell death and inflammation in Parkinson's disease model in vitro by potential targeting of MAVS
Ya‐Ling Yang, Tsu‐Kung Lin, Ying‐Hsien Huang
European Journal of Pharmacology (2022) Vol. 934, pp. 175302-175302
Open Access | Times Cited: 15
The role of micro-RNAs in neuropathic pain—a scoping review
Kesava Kovanur Sampath, Suzie Belcher, James Hales, et al.
PAIN Reports (2023) Vol. 8, Iss. 6, pp. e1108-e1108
Open Access | Times Cited: 9
Circulating plasma miR-23b-3p as a biomarker target for idiopathic Parkinson's disease: comparison with small extracellular vesicle miRNA
Sanskriti Rai, Prahalad Singh Bharti, Rishabh Singh, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 8
Confounding Factors Impacting microRNA Expression in Human Saliva: Methodological and Biological Considerations
Rhea Sullivan, Austin Montgomery, Anna Scipioni, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1874-1874
Open Access | Times Cited: 11
Salivary Biomarkers: Noninvasive Ways for Diagnosis of Parkinson’s Disease
Sanaz Salaramoli, Hamidreza Joshaghani, Seyed Isaac Hashemy
Neurology Research International (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 5
Combining salivary α-synuclein seeding activity and miRNA-29a to distinguish Parkinson's disease and multiple system atrophy
Mingyue Luan, Luhua Wei, Yunchuang Sun, et al.
Parkinsonism & Related Disorders (2024) Vol. 127, pp. 107088-107088
Closed Access | Times Cited: 1
Pathologic changes in neuronal intranuclear inclusion disease are linked to aberrant FUS interaction under hyperosmotic stress
Hui Wang, Yilei Zheng, Jiaxi Yu, et al.
Neurobiology of Disease (2023) Vol. 190, pp. 106391-106391
Open Access | Times Cited: 1
MiR-29a efficiently suppresses the generation of reactive oxygen species and α-synuclein in a cellular model of Parkinson's disease by potentially targeting GSK-3β
Ya‐Ling Yang, Tsu‐Kung Lin, Ying‐Hsien Huang
European Journal of Pharmacology (2024) Vol. 974, pp. 176615-176615
Open Access
miRNAs As Biomarkers for Neurodegenerative Diseases
Moisés Manuel Gallardo-Pérez, Solón Javier Garcés‐Eisele
Epigenetics and human health (2024), pp. 157-186
Closed Access
Parkinson’s disease patients combined with constipation tend to have higher serum expression of microRNA 29c, prominent neuropsychiatric disorders, possible RBD conversion, and a substandard quality of life
Hong Liu, Lei Shen, Haonan Zhao, et al.
Neurological Sciences (2023) Vol. 44, Iss. 9, pp. 3141-3150
Closed Access
MicroRNAs in Parkinson’s disease: A systematic review and diagnostic accuracy meta-analysis
Diane Guévremont, Joyeeta Roy, Nicholas J. Cutfield, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top